Search

In recent years, the use of cationic peptides as alternative drugs with anticancer activity has received attention. In this study, the targeted release of curcumin (Cur) and CM11 peptide alone and together against hepatocellular carcinoma (HCC) was evaluated using chitosan nanoparticles (CS NPs) coated with Pres1 that target the SB3 antigen of HCC cells (PreS1-Cur-CM11-CS NPs). SB3 protein is the specific antigen of HCC and the PreS1 peptide is a part of the hepatitis B antigen, which can specifically bind to the SB3 protein. Chitosan was used to prepare NPs. To Cur and CM11 loading, drugs were added to the CS solution in appropriate concentrations. Pres1 was coupled to the surface of the NPs using EDC catalyst to target NPs against HepG2 cells. SEM and DLS analysis confirmed that the PreS1-Cur-CM11-CS NPs had a size of about 132 nm, the ideal size for penetrating the cell membrane. The loading of Cur and CM11 was equal to 87% and 65%, respectively, which had a sustained and better release in the acidic environment than in the physiological environment. The MTT assay showed that PreS1-Cur-CM11-CS NPs act in a targeted and specific manner with the highest toxicity on the HepG2 cells compared to the control by a decrease in viability of about 26% after 48 h based on cell apoptosis. The results showed that PreS1-Cur-CM11-CS NPs are capable of targeted and specific drug release against HepG2 cancer cells and have significant potential to fight this cancer. [ABSTRACT FROM AUTHOR]

In the present study, we hypothesized that the presence of gallic acid as an additive antioxidant agent and alendronate can improve the osteogenic differentiation potency of human adipose mesenchymal stem cells, cultured on the scaffolds with fiber-microparticle structures. For this purpose, a combination of electrospinning and electrospraying techniques was employed to prepare a fiber-microparticle structure, composed of polycaprolactone (PCL)–alendronate (ALN) fibers/gallic acid-loaded chitosan nanoparticles (GNP) @ polyvinylpyrrolidone (PVP) microparticles. GNPs were fabricated by a cross-junction microfluidic device. By adjusting the gallic acid concentration, three types of GNPs were fabricated. The morphology of fabricated nanoparticles was quasi-sphere. %Loading efficiency increased by employing higher concentrations of gallic acid. According to dynamic light scattering results, the average hydrodynamic diameter of nanoparticles was between 213 and 217 nm. The impact of ALN concentration on the size and morphology of PCL electrospun scaffolds was separately investigated by SEM in which PCL/ALN 2.5% was selected for the next steps. The % porosity of all samples was around 62–68%. The release profile of ALN was slower than gallic acid. The % 1,1 diphenyl-2-picrylhydrazyl (DPPH) inhibition analysis showed that the presence of gallic acid could effectively improve the additive antioxidant properties of fabricated scaffolds. According to the MTT results, the presence of ALN could significantly improve the proliferation of human adipose mesenchymal stem cells. The alkaline phosphatase (ALP) activity and calcium deposition assessments on days 7, 14, and 21 and the evaluation of mRNA levels of ALP and osteopontin on days 7 and 14 confirmed the synergistic impact of gallic acid and ALN on osteogenic differentiation. [ABSTRACT FROM AUTHOR]

This systematic review was designed to answer the following question: Does chitosan provide better smear layer removal and antimicrobial efficacy than other root canal irrigants? A literature search was done using electronic databases PubMed, Scopus, Web of Science, Cochrane Library, EBSCO host, Grey Literature Report, and Open Grey from inception to June 18, 2024. The reference lists of included articles were also hand-searched. Two reviewers independently assessed the studies' eligibility based on the inclusion and exclusion criteria and performed data extraction. Two reviewers independently evaluated the risk of bias in the selected studies. The search retrieved 2330 studies. After analysis, 36 studies fulfilled the eligibility criteria and were included, with 19 involving smear layer removal, 16 involving antibacterial efficacy, and 1 involving both. The overall risk of bias of the included studies was medium. Chitosan removed the smear layer more effectively than citric acid and acetic acid, similar to MTAD and Qmix, with conflicting results against EDTA. In addition, chitosan demonstrated comparable antibacterial efficacy to chlorhexidine, propolis, and photodynamic therapy but was less effective than sodium hypochlorite. Based on available evidence, it was found that chitosan provided better smear layer removal and antimicrobial efficacy than most root canal irrigants compared in this systematic review. There was substantial heterogeneity in the methodology of included studies. As a result, this review highly recommends further research using standardized methods to assess the effectiveness of chitosan as a root canal irrigant in in-vitro studies to validate its clinical use. [ABSTRACT FROM AUTHOR]

The applications of resveratrol (RES) and puerarin (PUE) with notable physiological functions are greatly limited in functional food and pharmaceutical industries due to their poor water solubility and chemical instability. Accordingly, co‐loading of RES and PUE into chitosan‐based nanoparticles (NPs) is performed here by an anti‐solvent method to improve their bioavailability. The fabricated NPs at 8:1 mass ratio of carboxymethyl chitosan (CMC) to chitosan hydrochloride (CHC) with the particle size of 375.1 nm and zeta potential of +36.5 mV showed encouraging encapsulation efficiency and loading capacity at 85.2% (RES), 89.5% (PUE), and 15.5%. The microstructure of core–shell CMC–CHC was confirmed through dynamic light scattering and transmission electron microscopy. Molecular docking and storage stability indicating the more beneficial encapsulation of chitosan derivatives to PUE in comparison to RES. Cellular antioxidant activity experiments showed that the bioactivities of PUE/RES after loading with 20 and 40 mg·mL−1 were improved by 13.2% and 18.5%, respectively, with respect to free ones. Therefore, RES/PUE‐loaded CHC–CMC NPs were successfully prepared in this study, thus significantly improving the RES and PUE bioavailability and promoting their applications in functional food and pharmaceutical industries. [ABSTRACT FROM AUTHOR]

Summary: The objective of this study was to develop Tricholoma fracticum extract‐loaded chitosan nanoparticles (TFNPs) by ionic gelation method and to evaluate their in vitro antioxidant activity. Phenolic and flavonoid contents in the T. fracticum extract were measured spectrophotometrically and chromatographically. Characterisation of NPs was evaluated by field emission scanning electron microscopy (FE‐SEM), transmission electron microscopy (TEM), ZETA analysis, Fourier‐transform infrared spectroscopy (FT‐IR), UV–visible spectroscopy (UV–Vis) and thermogravimetric analysis (TGA). In vitro antioxidant capacity was determined using 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) and 2,2′‐azino‐bis(3‐ethylbenzothiazoline‐6‐sulfonic acid) (ABTS) assays. The phenolic and flavonoid contents in the T. fracticum extract were measured as 7.1 ± 0.3 mg Gallic Acid Equivalent/g extract and 5.5 ± 0.6 mg Quercetin Equivalent/g extract, respectively. The particle size, polydispersity index (PDI) and zeta potential of Blank NP1 and TFNP were 265.5 ± 15.8 nm, 0.4, 38.7 ± 4.0 mV and 333.2 ± 16.3 nm, 0.4, 37.0 ± 4.1 mV, respectively. The highest antioxidant activity was observed in TFNP, followed by T. fracticum extract, chitosan and blank NP, respectively. The preserved or enhanced antioxidant activity observed in the encapsulated T. fracticum extract indicates the potential for loading similar mushroom extracts onto chitosan and thus preserving their bioactive properties. [ABSTRACT FROM AUTHOR]

Aim and Objectives: The aim of the study was to compare and evaluate the push-out bond strength (POBS) of epoxy resin-based and calcium silicate-based sealers with and without incorporating chitosan nanoparticles (CSNPs). Methodology: Eighty human mandibular premolars with a single canal were taken. A standard root length of 15 mm was established. Canals were instrumented with Neoendo files up to size 30, 4% and were irrigated with 5 ml of 2.5% NaOCl, and 5 ml of ethylenediaminetetraacetic acid 17%. Then, samples were obturated using the size 30, 4% gutta-percha, single-cone technique using respective sealers. For POBS, it was grouped as Group 1 Adseal, Group 2 CeraSeal, Group 3 Adseal + 2% wt/vol CSNP, and Group 4 CeraSeal + 2% wt/vol CSNP. Samples embedded in acrylic resin were sectioned transversely at 11 and 7 mm from the apex. Dislodgment resistance was calculated using a universal testing machine. The data were analyzed using a one-way ANOVA test, followed by Tukey's post hoc analysis. The level of significance (P value) was set at P < 0.05. Results: At 7 mm from the apex, Group 4 (CeraSeal + 2% wt/vol CSNP) demonstrated significantly higher mean POBS. However, no significant difference was observed between Groups 1 (Adseal), Group 2 (CeraSeal), and Group 3 (Adseal + 2% wt/vol CSNP). At 11 mm from the apex, Group 2 (CeraSeal) and Group 4 (CeraSeal + 2% wt/vol CSNP) demonstrated significantly higher mean POBS. On comparison between POBS at 7 mm and 11 mm from the apex, the mean POBS at the 11 mm region from the apex was significantly higher in all study groups, which was statistically significant. Conclusion: Within the limitations of the study, it has been concluded that Group 4 (CeraSeal + 2% wt/vol CSNP) has better bond strength compared to the other groups. [ABSTRACT FROM AUTHOR]

Lung cancer is known as the most common cancer. Although the Ramucirumab antibody is a second‐line treatment for lung cancer, the high interstitial fluid pressure limits the antibody's performance. In this way, Imatinib is a chemotherapeutic drug to reduce the interstitial fluid pressure. Up to now, unfortunately, both Ramucirumab and imatinib have not been reported in one nanosystem for cancer therapy. To fulfill this shortcoming, this paper aims to design a chitosan nanocarrier that loads imatinib and attaches to Ramucirumab for selective bonding to A549. Therefore, this paper aims to develop a polymeric nanosystem for non‐small cell lung cancer (NSCLC) treatment. In first, the chitosan polyethylene glycol nanoparticle is synthesized, loaded with imatinib, and then targeted using Ramucirumab. Afterwards, the CS‐PEG‐Ab‐Im by FTIR, TEM, DLS, zeta potential, and TGA techniques are characterized. The size of CS‐PEG‐Ab‐Im was 25–30 nm, its surface charge was 13.1 mV, and the shape of CS‐PEG‐Ab‐Im was nearly spherical and cylindrical. The therapeutic potential of CS‐PEG‐Ab‐Im was assessed using the A549 cell line. According to the obtained results, the cell viability was 48% after 48 h of treatment of A549 cells using the IC50 concentration of CS‐PEG‐Ab‐Im (100 nanomolar). Moreover, the apoptosis and cell cycle arrest percentages were increased by 3 and 6 times, respectively, as compared to free imatinib. Furthermore, the release rate of imatinib from CS‐PEG‐Ab‐Im in an acidic medium was 17% during 1 h, indicating five times the imatinib release in the natural medium. Eventually, the result of flow cytometry indicates the more apoptotic effect of nanosystem to free imatinib and CS‐PEG‐Ab. Besides, cell arresting result exhibits the CS‐PEG‐Ab‐Im and causes cell arrested at G1 by %8.17. Thus, it can be concluded that CS‐PEG‐Ab‐Im can be an ideal nanosystem in NSCLC treatment. [ABSTRACT FROM AUTHOR]

Diabetic ketoacidosis (DKA) is regarded to be a communal complication of both type 1 and type 2 diabetes mellitus in children and adolescents. Successful therapy of DKA in children requires prompt diagnosis, strict monitoring of medical indicators, and prompt action. Thymoquinone (Tq) from black cumin loaded chitosan nanoparticles (ChNPs) intend to assess an effective agent to overcome this problem. XRD, FTIR, SEM, and TEM were used in the physicochemical analysis. Enzymatic activity of α-amylase and α-glucosidase was used in in vitro tests of anti-diabetic efficacy. Protecting insulin against enzyme breakdown is a crucial part of the insulin delivery mechanism. In the STZ-induced diabetes RIN-5F cell line, the anti-apoptotic capability of Tq-ChNPs was demonstrated through the NF-κB mediated apoptotic pathway. The combination of thymoquinone and chitosan NPs demonstrated that a wide variety of incredibly effective substances to elevate their curative effects, thus contributing to the growth of clinical and pharmaceutical fields.

Aim: Endodontic irrigants may affect the mechanical and chemical properties of dentine. This study evaluated the effects of various final irrigation protocols including the use of chitosan nanoparticle (CSnp) and cross‐linking with genipin on the (1) mechanical and (2) chemical properties of dentine against enzymatic degradation. Methodology: CSnp was synthesized and characterized considering physiochemical parameters and stability. The root canals of 90 single‐rooted teeth were prepared and irrigated with NaOCl. Dentine discs were obtained and divided into groups according to the following irrigation protocols: Group NaOCl+EDTA, Group NaOCl+CSnp, Group NaOCl+EDTA+CSnp, Group NaOCl+CSnp+Genipin, Group NaOCl+EDTA+CSnp+Genipin and Group distilled water. (1) Mechanical changes were determined by microhardness analysis using Vickers‐tester. (2) Chemical changes were determined by evaluating molecular and elemental compositions of dentine using Fourier transform infrared spectroscopy (FTIR) analysis and scanning electron microscope (SEM)/energy dispersive X‐ray spectroscopy (EDS) analysis, respectively. All analyses were repeated after the discs were kept in collagenase for 24 h. Data were analysed with repeated measures analysis of variance and Bonferroni correction for microhardness analysis, and Kruskal–Wallis and Wilcoxon tests for FTIR and SEM/EDS analyses (p =.05). Results: (1) Collagenase application did not have a negative effect on microhardness only in Group NaOCl+EDTA+CSnp+Genipin when compared with the post‐irrigation values (p >.05). Post‐collagenase microhardness of Group NaOCl+EDTA+CSnp and Group NaOCl+CSnp+Genipin was similar to the initial microhardness (p >.05). (2) After collagenase, Amide III/PO43− ratio presented no change in Group NaOCl+EDTA+CSnp, Group NaOCl+CSnp+Genipin and Group NaOCl+EDTA+CSnp+Genipin (p >.05), while decreased in other groups (p <.05). Collagenase did not affect CO32−/PO43− ratio in the groups (p >.05). There were no changes in the groups in terms of elemental level before and after collagenase application (p >.05). Conclusions: CSnp and genipin positively affected the microhardness and molecular composition of dentine. This effect was more pronounced when CSnp was used after EDTA. [ABSTRACT FROM AUTHOR]

Researchers are actively exploring biodegradable biocomposite films as environmentally friendly packaging solutions. Increasing consumer demand for a healthy and secure lifestyle led to a serious recent study into the development of intelligent food packaging bio-nanocomposite films aiming not only contribute to sustainability but also possess advanced functionalities through the integration of nanotechnology and intelligent features. This research focuses on the development of active and pH-responsive bio-nanocomposite films by incorporating various concentrations of SPE anthocyanins into the nanoparticle of the CH-PSPS matrix using the solvent-casting method. Thorough examination and characterization of the films revealed a smooth and compact surface, indicative of a uniform distribution of SPE anthocyanins within the matrix as observed through AFM analysis. The inclusion of SPE anthocyanins resulted in a significant increase in antioxidant activity, ranging from 16.37% to 26.44%. Additionally, all films containing SPE anthocyanins exhibited excellent UV barrier properties and demonstrated sensitivity to pH levels within the range of 1 to 10 in buffer solutions. Moreover, the films effectively preserved the freshness of the shrimp during storage. Consequently, these developed films showcase promising potential as active and intelligent packaging materials for food products. [ABSTRACT FROM AUTHOR]

Vitexin is a natural bioactive compound with many functional properties. However, its poor water solubility and dispersion stability and short half-life limit its practical applications for targeting specific sites. The current work demonstrates that encapsulation of vitexin in chitosan nanoparticles via an oil-in-water emulsion followed by ionic gelation using pentasodium triphosphate overcomes these limitations. The successful loading of vitexin into chitosan nanoparticles was confirmed using ultraviolet-visible spectroscopy, Fourier-transform infrared spectroscopy, X-ray diffraction, thermogravimetric analysis, and differential scanning calorimetry. The vitexin-loaded chitosan nanoparticles were spherical, 50–250 nm in diameter, and had a negatively charged surface (zeta potential of – 6.2 to – 13.8 mV), 2.8–21.0% loading capacity (LC), and 16.6–58.2% encapsulation efficiency. Vitexin LC increased with increasing initial concentration. The vitexin-loaded chitosan nanoparticles showed antioxidant and lipid oxidation retardation activities that increased as a function of LC. Encapsulation of vitexin into chitosan nanoparticles could improve its dispersion stability in water. Vitexin release from chitosan nanoparticles into the buffer media was faster at pH 11 (completed within 10 days) than at pH 7 (80 days) and 3 (> 4 months). These results suggest that vitexin-loaded chitosan nanoparticles are stable in acidic and neutral pH media, and the loaded vitexin can potentially withstand the harsh gastrointestinal (GI) environment. The in vitro simulated GI digestion confirms the enhanced bioaccessibility of vitexin after loading into chitosan nanoparticles. [ABSTRACT FROM AUTHOR]

In this work, we described novel composite films derived from CMC (carboxymethyl cellulose) and ST (starch) polymers reinforced CS NPs (chitosan nanoparticles) achieved by the solution casting method. The CS NPs were prepared using an ionic gelation method utilizing chitosan with sodium alginate, and employed as a reinforcing phase for the development of CMC/ST-CS NPs (CSC) bio-nanocomposite films with different content of the CS NPs loading levels (0, 1, 3, 6 and 9 wt%) described. The prepared film interactions and compatibility between the polymers were established using FT-IR, X-ray diffraction, and SEM. The tensile strength (~ 81.08%), UV blocking (~ 34.50%), moisture content (~ 54.12%), and permeability [oxygen (~ 45.93%) and water vapor permeability (~ 68.62%)] properties of the prepared films were determined. The overall migration limit of the prepared CSC films showed below the permitted limit of 1000 μg/dm2. The prepared films showed antioxidant (~ 42.35%) and very good cell viability properties (more than 90%). Further, prepared CSC films displayed the potential to extend the shelf–life of the chicken meat up to 56 h, when stored at room temperature. These experimental results suggested that, prepared CSC film is well suitable for the potential active packaging purpose. [ABSTRACT FROM AUTHOR]

The COVID-19 outbreak was a global pandemic with wide-ranging healthcare implications. Although several mRNA-based vaccines delivered using lipid nanoparticles (LNP) have been approved and demonstrated efficacy at reducing the severity and spread of infection, continued rapid viral evolution and disadvantages currently associated with LNP delivery vehicles (such as toxicity) are driving the design of next-generation SARS-CoV-2 vaccines. Herein, we describe the development of a trimethylated chitosan-based nanoparticle layer-by-layer (LbL) delivery platform for multiple antigens as a scalable and safe COVID-19 vaccine, known as, "LbL-CoV19". These vaccine candidates have been demonstrated to be biocompatible, safe, and effective at stimulating both humoral and cellular responses for protection in preclinical studies. Preliminary results also indicate that LbL-CoV19 can potentially achieve rapid, long-lasting, and broad protection against the SARS-CoV-2 challenge. The "plug-and-play" platform technology is well suited to preparedness for future pandemics and disease outbreaks. [ABSTRACT FROM AUTHOR]

Introduction: Fumaria has been traditionally used to treat skin damages due to anti-inflammatory properties. In the present study, we evaluated the effect of the ethanolic extract of Fumaria parviflora Lam. (F. parviflora) against Leishmania major (L. major) using chitosan biopolymer drug delivery system both In vitro and In vivo models. Materials and Methods: The ethanolic extract of F. parviflora was analyzed by HPLC to determine its active ingredients content. The extract was then loaded on chitosan nanoparticles (CNPs). The parasite was treated with various concentrations of the ethanolic extract, CNPs and CNPs loaded with F. parviflora extract (CNPs@ F. parviflora). The size of lesions of treated mice were measured on a weekly basis. The parasite burden was evaluated 8 weeks after treatment. Results: The HPLC analysis showed the presence of Fumaric acid at a high concentration. The percentage of the drug released from CNPs@ F. parviflora within 24 and 72 h were 65% and 90% respectively. The results showed that F. parviflora extract and CNPs@ F. parviflora caused 84% and 96% growth inhibition of L. major promastigotes as revealed by Neubauer chamber counting and MTT test respectively. The IC50 values of F. parviflora extract and CNPs@ F. parviflora were 450 and 68.4 µg/ml respectively. In amastigote assay, the best results showed in CNPs@ F. parviflora that only 2% of macrophages were infected with amastigotes. In vivo experiments for mice treated with F. parviflora and CNPs @ F. parviflora in comparison to control group showed a significant reduction (P < 0.05) in the mean diameter of the lesions (2.3 and 1.72 mm and 9.91 mm respectively). Conclusion: The ethanolic extract of F. parviflora both as standalone and loaded in CNPs showed promising inhibitory effects against L. major both upon In vitro and In vivo experimentation as well as therapeutic effects for wound healing in infected mice. [ABSTRACT FROM AUTHOR]

Objective To construct the chitosan/BMP-2 plasmid thermosensitive hydrogel complex CS/CSn（pDNA-BMP2）-GP，and evaluate the effect of this composite system on alveolar bone regeneration in beagle dogs. Methods Periodontitis models were established in the second and third premolars from 4 beagle dogs. All teeth were randomly divided into three groups： CS/CSn-GP group，CS/CSn（pDNA-BMP2）-GP group and blank control group. In the CS/CSn-GP group，CS/CSn-GP was injected. In the CS/CSn（pDNA-BMP2）-GP group，CS/CSn（pDNA-BMP2）-GP was injected. In the blank control group，no material was injected. All animals were sacrificed 8 weeks later. The alveolar bone regeneration in periodontitis was observed by Masson staining. The expression of alkaline phosphatase （ALP） in bone defects was observed by calcium and cobalt staining. Results Masson staining showed that different degrees of alveolar bone regeneration was noted in the CS/CSN-GP and CS/CSn（pDNA-BMP2）-GP groups，and significant regeneration was noted in the CS/CSn（pDNA-BMP2）-GP group. Calcium and cobalt staining revealed strongly-positive ALP in the CS/CSn（pDNA-BMP2）-GP group，weakly-positive ALP in the CS/ CSN-GP group，and negative result in the blank control group. The average optical density value in the ALP-positive staining area in the CS/CSn（pDNA-BMP2）-GP group was higher than that in the CS/CSn-GP group，followed by that in the blank control group（all P < 0.05）. Conclusions CS/CSn-GP composite repair system exerts positive effect on alveolar bone regeneration. Inclusion of pDNA-BMP2 can significantly promote the effect on alveolar bone regeneration.

Synergistic immunotherapy of immune checkpoint blockade (ICB) and immunogenic cell death (ICD) has shown remarkable therapeutic efficacy in various cancers. However, patients show low response rates and undesirable outcomes to these combination therapies owing to the recycling mechanism of programmed death-ligand 1 (PD-L1) and the systemic toxicity of ICD-inducing chemotherapeutic drugs. Herein, we propose all-in-one glycol chitosan nanoparticles (CNPs) that can deliver anti-PD-L1 peptide (PP) and doxorubicin (DOX) to targeted tumor tissues for a safe and more effective synergistic immunotherapy. The PP-CNPs, which are prepared by conjugating ᴅ-form PP (NYSKPTDRQYHF) to CNPs, form stable nanoparticles that promote multivalent binding with PD-L1 proteins on the targeted tumor cell surface, resulting in effective lysosomal PD-L1 degradation in contrast with anti-PD-L1 antibody, which induces recycling of endocytosed PD-L1. Consequently, PP-CNPs prevent subcellular PD-L1 recycling and eventually destruct immune escape mechanism in CT26 colon tumor-bearing mice. Moreover, the ICD inducer, DOX is loaded into PP-CNPs (DOX-PP-CNPs) for synergistic ICD and ICB therapy, inducing a large number of damage-associated molecular patterns (DAMPs) in targeted tumor tissues with minimal toxicity in normal tissues. When the DOX-PP-CNPs are intravenously injected into CT26 colon tumor-bearing mice, PP and DOX are efficiently delivered to the tumor tissues via nanoparticle-derived passive and active targeting, which eventually induce both lysosomal PD-L1 degradation and substantial ICD, resulting in a high rate of complete tumor regression (CR: 60%) by a strong antitumor immune response. Collectively, this study demonstrates the superior efficacy of synergistic immunotherapy using all-in-one nanoparticles to deliver PP and DOX to targeted tumor tissues.

ABSTRACT: Non-typhoidal Salmonella infection is a significant health and economic burden in poultry industry. Developing an oral vaccine to induce robust mucosal immunity in the intestines of birds, especially cross protection against different Salmonella serotypes is challenging. Therefore, a potent oral vaccine platform that can mitigate different serotypes of Salmonella is warranted for the poultry industry. We reported earlier that the Salmonella enteritidis (SE) immunogenic outer membrane proteins (OMPs) and flagellin (FLA) entrapped in mannose chitosan nanoparticles (OMPs-FLA-mCS NPs) administered prime-boost (d-3 and 3-wk later) by oral inoculation elicits mucosal immunity and reduces challenge SE colonization by over 1 log10 CFU in birds. In this study, we sought to evaluate whether the SE antigens containing OMPs-FLA-mCS NPs vaccine induces cross-protection against Salmonella typhimurium (ST) in broilers. Our data indicated that the OMPs-FLA-mCS NPs vaccine induced higher cross-protective antibody responses compared to commercial Poulvac ST vaccine (contains a modified-live ST bacterium). Particularly, OMPs-FLA-mCS-NP vaccine elicited OMPs and FLA antigens specific increased production of secretory IgA and IgY antibodies in samples collected at both post-vaccination and post-challenge timepoints compared to commercial vaccine group. Notably, the vaccine reduced the challenge ST bacterial load by 0.8 log10 CFU in the cecal content, which was comparable to the outcome of Poulvac ST vaccination. In conclusion, our data suggested that orally administered OMPs-FLA-mCS-NP SE vaccine elicited cross protective mucosal immune responses against ST colonization in broilers. Thus, this candidate vaccine could be a viable option replacing the existing both live and killed Salmonella vaccines for birds.

The purpose of this systematic review of meta‐analysis was to compare the effectiveness of removing the smearing layer using EDTA versus Chitosan (Ch) and Chitosan nanoparticles (Ch‐NPs). A search was performed in four electronic databases (Web of Science, PubMed, Scopus, and Cochrane). The included studies were assessed by two reviewers using Joanna Briggs Institute's critical appraisal checklist for the quasi‐experimental studies. Outcomes obtained by scanning electron microscopy (SEM) and conventional methods were presented as standardized mean differences alongside 95% confidence intervals. Seven investigations employed 212 single‐root teeth. In the apical section (p =.317, 95% CI = −0.820 to 0.266, Tau2 = 0.387), middle segment (p =.914, 95% CI = −1.019 to 0.912, Tau2 = 1.027), and coronal segment (p =.277, 95% CI = −1.008 to 0.289, Tau2 = 0.378). This meta‐analysis found no difference between Ch, Ch‐NPs, and EDTA in removing the smear layer in the three segments. This systematic review is designed to show evidence related to the PICO question, in which our outcome is smear layer removal and not the clinical success of such a treatment. Research Highlights: The study aimed to compare the effectiveness of chitosan and chitosan nanoparticles with ethylenediaminetetraacetic acid (EDTA) in removing the smear layer, a layer of debris and organic material on the tooth surface, through a systematic review and meta‐analysis.The removal of the smear layer is crucial for successful dental treatments, as it enhances the adhesion of restorative materials and improves the penetration of antimicrobial agents into dentinal tubules.The researchers conducted a systematic review and meta‐analysis, searching various databases of electron microscopy results for relevant in vitro studies comparing the effects of chitosan or chitosan nanoparticles with EDTA on smear layer removal.The results encourage further exploration of chitosan and chitosan nanoparticles for clinical use in dentistry, while considering their specific applications and long‐term effects. [ABSTRACT FROM AUTHOR]

Resistance to antimicrobial agents has created potential problems in finding efficient treatments against bacteria. Thus, using new therapeutics, such as recombinant chimeric endolysin, would be more beneficial for eliminating resistant bacteria. The treatment ability of these therapeutics can be further improved if they are used with biocompatible nanoparticles like chitosan (CS). In this work, covalently conjugated chimeric endolysin to CS nanoparticles (C) and non-covalently entrapped endolysin in CS nanoparticles (NC) were effectively developed and, consequently, qualified and quantified using analytical devices, including FT-IR, dynamic light scattering, and TEM. Eighty to 150 nm and 100 nm to 200 nm in diameter were measured for CS-endolysin (NC) and CS-endolysin (C) using a TEM, respectively. The lytic activity, synergistic interaction, and biofilm reduction potency of nano-complexes were investigated on Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), and Pseudomonas aeruginosa (P. aeruginosa) strains. The outputs revealed a good lytic activity of nano-complexes after 24 h and 48 h of treatment, especially in P. aeruginosa (approximately 40% cell viability after 48 h of treatment with 8 ng/mL), and potential biofilm reduction performance was attained in E. coli strains (about 70% reduction after treatment with 8 ng/mL). The synergistic interaction between nano-complexes and vancomycin was exhibited in E. coli, P. aeruginosa, and S. aureus strains at 8 ng/mL concentrations, while the synergistic effects of pure endolysin and vancomycin were not remarkable in E. coli strains. These nano-complexes would be more beneficial in suppressing the bacteria with a high level of antibiotic resistance. [ABSTRACT FROM AUTHOR]

Copyright of Journal of New Medicine is the property of Sun Yat Sen University and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The date palm, or Phoenix dactylifera L., is one of the world's oldest fruit trees. The entire date palm tree is used to produce a variety of goods, including food, clothing, fibre, and shelter. Tissue culture is one of the most recent methods used to multiply date palms and produce disease-free offspring. Plant tissue culture technology has advantages over conventional methods of propagation for the quick and extensive multiplication of significant plants in vitro, regardless of the season, and disease-free. This is because it preserves space and time. For this study, three different cultivars were used (Barhy, Sakkoti, and Shamia). For the three cultivars, ¾ MS medium supplemented with 1 mg/L indole butyric acid IBA and 0.25 mg/l activated charcoal (AC) provided the optimal in vitro culture conditions. Plant gene function research and cultivar development are now both possible thanks to the advancement of plant transformation technologies. Date palm plants were given the AT1G12660 "Thio-60" gene to make them resistant to fungus infection. Utilizing chitosan nanoparticles for genetic transformation, the gene was introduced into three cultivars of dates (Barhy, Sakkoti, and Shamia). Run a conventional PCR to verify genetic fusion into all three cultivars. The fungal infection with Fusarium oxysporum was used to determine the resistance of the transgenic cultivar lines after it was established that the thionin gene had been transferred into transgenic date palm cultivars. Date crop transgenic lines showed strong resistance and a decline in the percentage of fungal infection-induced inhibition. Key message: Phoenix dactylifera in vitro culture was optimized on MS medium supplemented with phytohormones. Chitosan nanoparticle was applied for thionin genetic transformation into different cultivars to be resistant to Fusarium infection. [ABSTRACT FROM AUTHOR]

Purposes: Generalized anxiety is one of the most frequent anxiety problems. This study aimed to improve the distribution of venlafaxine HCl (Ven) in the brain by using Tween 80-coated chitosan nanoparticles made by ionic gelation. Methods: The impact of the proportion of chitosan (CS): tripolyphosphate (TPP) and surface coating on the formulations were investigated. Differential scanning calorimetry (DSC), attenuated total reflectance–Fourier transform infrared (ATR-FTIR) spectroscopy, drug release, scanning electron microscopy (SEM), and animal bio-distribution model, and cellular safety assessment were applied to investigate the characteristics, morphology, and effectiveness of the Ven nanoparticle. Results: The drug entrapment efficiency (80.69 ± 1.91%), particle size (248.066 ± 7.385 nm), polydispersity index (0.286 ± 0.012), and zeta potential (-13.93 ± 1.65 mV) of Tween 80-coated and Ven-incorporated chitosan nanoparticles were determined to be adequate. In vitro drug release from uncoated (62.758 ± 3.581%) and Tween 80-coated nanoparticles (30.682 ± 3.225%) demonstrated sustained release over 24 h compared with Ven solution. Furthermore, the cell safety of both coated and uncoated nanoparticles showed that they were nontoxic. In vivo bio-distribution investigations in mice revealed that Tween 80-coated Ven-entrapped chitosan nanoparticles had greater Ven amounts (474.393 ± 52.100 ng/ml) in the brain tissue after 1 h of oral administration than uncoated Ven-entrapped chitosan nanoparticles (357.815 ± 39.624 ng/ml) and Ven solution (122.752 ± 38.075 ng/ml). Conclusion: These findings indicated that surface-coated, Ven-loaded chitosan nanoparticles might become a viable technique for improving Ven brain uptake and ultimately opening up new pathways for generalized anxiety disorder management. [ABSTRACT FROM AUTHOR]

Background: This study evaluated the effect of using chitosan, nano-chitosan, and ethylenediaminetetraacetic acid (EDTA) as final irrigating solutions on smear layer cleanliness and Ca/P ratio of dentin. Methodology: Forty-eight decoronated human single-rooted teeth were used. They were divided randomly into four groups (n = 12) based on the final irrigating solution used as follows: (a) control group (IA; n = 6) normal saline, (IB; n = 6) were left unprepared; group II - 0.2% chitosan; group III - 0.2% nano-chitosan; and group IV - 17% EDTA. Samples were prepared using ProTaper Next and irrigated with 2.6% NaOCl 5 ml after each instrument using 31-gauge needle. Final rinse was used 5 ml/3 min according to the assigned group. The specimens were prepared for evaluation. Results: Best smear layer removal was observed in group IV. No statistically significant differences (P > 0.05) were observed between the experimental groups (II, III, and IV) coronally; however, a statistically significant difference (P < 0.05) was observed between groups II and IV at middle and apical thirds. Intragroup comparison showed that apical third exhibited the highest mean smear layer score among all experimental groups. The highest mean Ca/P ratio was in the 0.2% nano-chitosan group, while the highest calcium loss was in the 17% EDTA group. Conclusions: 17% EDTA is a potent chelating agent that can successfully remove the smear layer but compromises the Ca/p ratio of dentin. However, 0.2% chitosan and its nanoparticles have comparable chelating effects and induce remineralization of the root canal dentin.

The COVID-19 outbreak was a global pandemic with wide-ranging healthcare implications. Although several mRNA-based vaccines delivered using lipid nanoparticles (LNP) have been approved and demonstrated efficacy at reducing the severity and spread of infection, continued rapid viral evolution and disadvantages currently associated with LNP delivery vehicles (such as toxicity) are driving the design of next-generation SARS-CoV-2 vaccines. Herein, we describe the development of a trimethylated chitosan-based nanoparticle layer-by-layer (LbL) delivery platform for multiple antigens as a scalable and safe COVID-19 vaccine, known as, “LbL-CoV19”. These vaccine candidates have been demonstrated to be biocompatible, safe, and effective at stimulating both humoral and cellular responses for protection in preclinical studies. Preliminary results also indicate that LbL-CoV19 can potentially achieve rapid, long-lasting, and broad protection against the SARS-CoV-2 challenge. The “plug-and-play” platform technology is well suited to preparedness for future pandemics and disease outbreaks.

The influence of ultrasonic processing parameters including reaction temperature (60, 70 and 80 °C), time (0, 15, 30, 45 and 60 min) and amplitude (70, 85 and 100%) on the formation and antioxidant activity of Maillard reaction products (MRPs) in a solution of chitosan and glucose (1.5 wt% at mass ratio of 1:1) was investigated. Selected chitosan-glucose MRPs were further studied to determine the effects of solution pH on the fabrication of antioxidative nanoparticles by ionic crosslinking with sodium tripolyphosphate. Results from FT-IR analysis, zeta-potential determination and color measurement indicated that chitosan-glucose MRPs with improved antioxidant activity were successfully produced using an ultrasound-assisted process. The highest antioxidant activity of MRPs was observed at the reaction temperature, time and amplitude of 80 °C, 60 min and 70%, respectively, with ∼ 34.5 and ∼20.2 μg Trolox mL−1 for DPPH scavenging activity and reducing power, respectively. The pH of both MRPs and tripolyphosphate solutions significantly influenced the fabrication and characteristics of the nanoparticles. Using chitosan-glucose MRPs and tripolyphosphate solution at pH 4.0 generated nanoparticles with enhanced antioxidant activity (∼1.6 and ∼ 1.2 μg Trolox mg−1 for reducing power and DPPH scavenging activity, respectively) with the highest percentage yield (∼59%), intermediate particle size (∼447 nm) and zeta-potential ∼ 19.6 mV. These results present innovative findings for the fabrication of chitosan-based nanoparticles with enhanced antioxidant activity by pre-conjugation with glucose via the Maillard reaction aided by ultrasonic processing.

Chitosan is a fibrous compound derived from chitin, which is the second most abundant natural polysaccharide and is produced by crustaceans, including crabs, shrimps, and lobsters. Chitosan has all of the important medicinal properties, including biocompatibility, biodegradability, and hydrophilicity, and it is relatively nontoxic and cationic in nature. Chitosan nanoparticles are particularly useful due to their small size, providing a large surface-to-volume ratio, and physicochemical properties that may differ from that of their bulk counterparts; thus, chitosan nanoparticles (CNPs) are widely used in biomedical applications and, particularly, as contrast agents for medical imaging and as vehicles for drug and gene delivery into tumors. Because CNPs are formed from a natural biopolymer, they can readily be functionalized with drugs, RNA, DNA, and other molecules to target a desired result in vivo. Furthermore, chitosan is approved by the United States Food and Drug Administration as being Generally Recognized as Safe (GRAS). This paper reviews the structural characteristics and various synthesis methods used to produce chitosan nanoparticles and nanostructures, such as ionic gelation, microemulsion, polyelectrolyte complexing, emulsification solvent diffusion, and the reverse micellar method. Various characterization techniques and analyses are also discussed. In addition, we review drug delivery applications of chitosan nanoparticles, including for ocular, oral, pulmonary, nasal, and vaginal methodologies, and applications in cancer therapy and tissue engineering. [ABSTRACT FROM AUTHOR]

Background: This study evaluated the effect of using chitosan, nano-chitosan, and ethylenediaminetetraacetic acid (EDTA) as final irrigating solutions on smear layer cleanliness and Ca/P ratio of dentin. Methodology: Forty-eight decoronated human single-rooted teeth were used. They were divided randomly into four groups (n = 12) based on the final irrigating solution used as follows: (a) control group (IA; n = 6) normal saline, (IB; n = 6) were left unprepared; group II - 0.2% chitosan; group III - 0.2% nano-chitosan; and group IV - 17% EDTA. Samples were prepared using ProTaper Next and irrigated with 2.6% NaOCl 5 ml after each instrument using 31-gauge needle. Final rinse was used 5 ml/3 min according to the assigned group. The specimens were prepared for evaluation. Results: Best smear layer removal was observed in group IV. No statistically significant differences (P > 0.05) were observed between the experimental groups (II, III, and IV) coronally; however, a statistically significant difference (P < 0.05) was observed between groups II and IV at middle and apical thirds. Intragroup comparison showed that apical third exhibited the highest mean smear layer score among all experimental groups. The highest mean Ca/P ratio was in the 0.2% nano-chitosan group, while the highest calcium loss was in the 17% EDTA group. Conclusions: 17% EDTA is a potent chelating agent that can successfully remove the smear layer but compromises the Ca/p ratio of dentin. However, 0.2% chitosan and its nanoparticles have comparable chelating effects and induce remineralization of the root canal dentin. [ABSTRACT FROM AUTHOR]

Starch-based nanocomposite films containing chitosan nanoparticles (S/CNP films) are biodegradable and promising alternatives for non-biodegradable synthetic plastics. Nonetheless, limited work has been conducted to investigate the biodegradability of the films in soil. Thus, this work is aimed at investigating the biodegradation of starch-based films containing different concentrations of CNP (0, 10, 15, 20, 25% w/w solid starch) via a soil burial test using compost and planting soils. The biodegradability was investigated in terms of weight loss, visual appearance, morphology, and structural changes. It was found that S/CNP films biodegraded slower than neat starch films, and the degradation rate was reduced by 46 and 44% in compost and planting soils, respectively, with the increase in the concentrations of CNP from 10 to 25% w/w incorporated into the films. The degradation rate of films in compost soil after 8 days was found to be higher (0.0617 g/day) than in planting soil (0.0266 g/day). Visual appearance, morphology, and structural change results also supported these findings. The biodegradable S/CNP films can be used to reduce the usage of synthetic plastic. [ABSTRACT FROM AUTHOR]

Colon-targeted delivery offers several benefits for oral protein delivery, such as low proteolytic enzyme activity, a natural pH environment, and extended residence time, which improve the bioavailability of the encapsulated protein. Therefore, we hypothesize that developing a novel colonic nanocarrier system, featuring modified chitosan that is soluble at physiological pH and coated with a colon-degradable polymer, will provide an effective delivery system for oral insulin. This study aims to synthesize insulin-loaded pectin-trimethyl chitosan nanoparticles (Ins-P-TMC-NPs) as an oral insulin delivery system and to evaluate its efficacy both in vitro and in vivo. N -trimethyl chitosan (TMC), synthesized via a methylation method, was used to prepare insulin-TMC nanoparticles coated with pectin via the ionic gelation method. The nanoparticles were characterized for their physicochemical properties, cumulative release profile, and surface morphology. The in vitro biological cytotoxicity and cellular uptake of the nanoparticles were evaluated against HT-29 cells. The in vivo blood glucose-lowering effect and histological toxicity were assessed in diabetic male Sprague–Dawley rats. The results showed that Ins-P-TMC-NPs were spherical, with an average size of 379.40 ± 40.26 nm, a polydispersity index of 24.10 ± 1.03 %, a zeta potential of +17.20 ± 0.52 mV, and a loading efficiency of 83.21 ± 1.23 %. Compared to uncoated TMC nanoparticles, Ins-P-TMC-NPs reduced insulin loss in simulated gastrointestinal fluid by approximately 67.23 ± 0.97 % and provided controlled insulin release in simulated colonic fluid. In vitro bioactivity studies revealed that Ins-P-TMC-NPs were non-toxic, with cell viability of 91.12 ± 0.91 % after 24 h of treatment, and exhibited high cellular uptake in the HT-29 cell line with a fluorescence intensity of 37.80 ± 2.40 after 4 h of incubation. Furthermore, the in vivo study demonstrated a sustained reduction in blood glucose levels after oral administration of Ins-P-TMC-NPs, peaking after 8 h with a blood glucose reduction of 87 ± 1.03 %. Histological sections showed no signs of toxicity when compared to those of healthy rats. Overall, the developed colon-targeted oral insulin delivery system exhibits strong potential as a candidate for effective oral insulin administration. [Display omitted] [ABSTRACT FROM AUTHOR]

Introduction: MicroRNAs (miRNAs) are short-sequence RNAs that regulate gene expression by targeting messenger RNAs (mRNAs). Recent studies reveal that miRNA-324-5p plays an important role in worsening the ovarian cancer prognosis when the expression is very high. This study aimed to develop a miRNA targeted therapy by targeting the miRNA-324-5p function as a miRNA-324-5p inhibitor. Methods: Chitosan nanoparticles were used for antimiRNA-324-5p delivery into SKOV3 cell lines formulated by ionic gelation method. Antiproliferative effect of CS-NPs-antimiRNA was assessed by the MTT Assay. A mechanism study assessed the anticancer effect of the formula. In silico analysis used miRTar.Human and StarmiRDB combined with Genecard to predict the target genes of antimiR. Hawkdock web server was used to analyze protein-protein interactions that were further validated by quantitative polymerase chain reaction (qPCR). Results: The results of qPCR analysis showed endogenous miRNA-324-5p decreased after 24-hour transfection of antagonist miRNA. Furthermore, the MTT assay results showed that antimiRNA was able to inhibit SKOV3 cell proliferation (80 nM 68.13%, P

The rising prevalence of impaired wound healing and the consequential healthcare burdens have gained increased attention over recent years. This has prompted research into the development of novel wound dressings with augmented wound healing functions. Nanoparticle (NP)-based delivery systems have become attractive candidates in constructing such wound dressings due to their various favourable attributes. The non-toxicity, biocompatibility and bioactivity of chitosan (CS)-based NPs make them ideal candidates for wound applications. This review focusses on the application of CS-based NP systems for use in wound treatment. An overview of the wound healing process was presented, followed by discussion on the properties and suitability of CS and its NPs in wound healing. The wound healing mechanisms exerted by CS-based NPs were then critically analysed and discussed in sections, namely haemostasis, infection prevention, inflammatory response, oxidative stress, angiogenesis, collagen deposition, and wound closure time. The results of the studies were thoroughly reviewed, and contradicting findings were identified and discussed. Based on the literature, the gap in research and future prospects in this research area were identified and highlighted. Current evidence shows that CS-based NPs possess superior wound healing effects either used on their own, or as drug delivery vehicles to encapsulate wound healing agents. It is concluded that great opportunities and potentials exist surrounding the use of CSNPs in wound healing.

Based on the recent research, the natural polysaccharide rich biopolymer of chitosan is an important carrier molecule for drug loading. In addition, the plant essential oils were another important material that frequently used to treat various infectious diseases. In addition, the chitosan loaded essential oils were heightened recent years due to the excellent biomedical properties. In this regard, the current study result was concentrated with encapsulation of plant essential oils into the chitosan nanoparticles for inhibit against A549 human lung cancer cells. In result, the unique and uniform size morphology of chitosan was clearly shown in scanning electron microscope (SEM) and transmission electron microscope (TEM). Further, the IC50 dose of the chitosan loaded essential oils at 1000 µg/mL concentration against A549 lung cancer cells was confirmed using cytotoxicity assay and this concentration was very effective than chitosan and essential oils alone. At 1000 µg/mL concentration, the high proliferation efficiency with unclear morphological evidence of A549 lung cancer cells was shown in phase contrast microscope. In addition, the AO/EB stain result was indicated more death cells with belbing formation of the treated cells were observed. At 1000 µg/mL of IC50 concentration of chitosan loaded essential oils was damaged the A549 lung cancer cells with high necrotic cells, chromatin condensation, and decreased cell division. Therefore, all the invitro experiments results were clearly stated that the chitosan loaded essential oils as more efficient alternative option to inhibit the cancer cells.

A breakthrough in cosmeceuticals by utilizing insects as major ingredients in cosmetic products is gaining popularity. Therefore, the interest in rare sources of ingredients, for instance, from the Oryctes rhinoceros beetle, can bring huge benefits in terms of turning pests into wealth. In this study, curcumin was chosen as the active ingredient loaded into chitosan-gold nanoparticles (CCG-NP). Curcumin is unstable and has poor absorption, a high rate of metabolism, and high sensitivity to light. These are all factors that contribute to the low bioavailability of any substance to reach the target cells. Therefore, chitosan extracted from O. rhinoceros could be used as a drug carrier to overcome these limitations. In order to overcome these limitations, CCG-NPs were synthesized and characterized. Chitosan was isolated from O. rhinoceros and CCG-NPs were successfully synthesized at 70 °C for 60 min under optimal conditions of a reactant ratio of 2:0.5 (0.5 mM HAuCl4: 0.1% curcumin). Characterizations of CCG-NP involved FTIR analysis, zeta potential, morphological properties determination by FE-SEM, particle size analysis, crystallinity study by XRD, and elemental analysis by EDX. The shape of the CCG-NP was round, its size was 128.27 d.nm, and the value of the zeta potential was 20.2 ± 3.81 mV. The IC50 value for cell viability is 58%, indicating a mild toxicity trait. To conclude, CCG-NP is a stable, spherical, nano-sized, non-toxic, and homogeneous solution. [ABSTRACT FROM AUTHOR]

BACKGROUND: Titanium as a bone substitute material has been widely used in the field of oral implant devices, but its bioinert would affect the stable combination with bone tissue at the early stage of implantation. Therefore, exploring to improve the osteogenic properties of titanium through surface modification is necessary. OBJECTIVE: To investigate the effect of composite coating of aspirin loaded chitosan nanoparticles and polydopamine on the viability of osteoblasts in vitro. METHODS: The titanium sheets modified by polydopamine coating as well as aspirin loaded chitosan nanoparticles and polydopamine composite coating were constructed. The surface morphology and microstructure of the coatings were characterized by scanning electron microscopy. In vitro sustained-release properties of aspirin nanosphere coatings on pure titanium were detected. Rat bone marrow mesenchymal stem cells were seeded and cultured on the pure titanium sheet and the two kinds of modified titanium sheets. The spreading morphology of rat bone marrow mesenchymal stem cells on the surface of titanium sheets was observed by cytoskeleton staining. Cell proliferation was determined by CCK-8 assay. The osteogenic differentiation of rat bone marrow mesenchymal stem cells on titanium sheets was measured using alkaline phosphatase staining and immunofluorescence staining. RESULTS AND CONCLUSION: (1) Scanning electron microscope images showed that the pure titanium surface was relatively smooth, and deposits as well as grain appeared after the dopamine polymerization. Aspirin microspheres were spherical with uniform size distribution. The hydrophilicity of the nanoparticles immobilized titanium surfaces and the polydopamine coating modified titanium surfaces were better than that of the pure titanium sheets (P < 0.05). The aspirin appeared to be slow and sustained under the encapsulation of chitosan nanoparticles. (2) As observed by cytoskeleton staining, the cells showed insufficient cell expansion on the surface of the pure titanium sheets and formed a few filopodia on the dopamine modified titanium sheets. The cells on nanoparticles modified sheets showed perfect expansion. (3) CCK-8 assay showed that the titanium sheets had no obvious cytotoxicity, and the cell proliferation rate of the nanoparticles modified titanium sheets displayed higher rates of proliferation than that of the dopamine coated and pure titanium sheets with increasing cell culture time (P < 0.05). (4) Alkaline phosphatase activity was highest on the surfaces of nanoparticles modified sheets. Immunofluorescence showed that the fluorescence intensity of alkaline phosphatase was strongest. (5) The results showed that the sustained-release coating of aspirin loaded chitosan nanoparticles on the titanium surfaces could enhance the proliferation and adhesion of rat bone marrow mesenchymal stem cells and promote osteogenic differentiation. [ABSTRACT FROM AUTHOR]

Background: This study aims to prepare high stability chitosan nanoparticles (CNP) and examine the ability of CNP in CpG-ODN delivery when treating allergic mice model. Methods: Preparation and characterization of CNP were performed by ionic gelation, dynamic light scattering, and zeta sizer. The CNP cytotoxicity and activation ability of CpG ODN delivered with CNP were tested using a cell counting kit-8 and Quanti blue method. Allergic mice were injected intraperitoneal with 10 ug ovalbumin on day 0 and 7, and then treated with intranasal CpG ODN/CpG ODN, delivered with CNP/CNP, on the third week three times per week for three weeks. The ELISA method measured cytokine and IgE profiles in the allergic mice's plasma and spleen. Results: CNP results have sizes 27.73 nm±3.67 dan 188.23 nm±53.47, spherical in shape and nontoxic, and did not alter the NF-κB activation of CpG ODN in RAW-blue cells. The application of CpG ODN delivered by chitosan nanoparticles shows no statistical difference between groups of IFN-κ, IL-10, and IL-13 in Balb/c mice's plasma and spleen, in contrast with IgE level. Conclusions: The results showed that using chitosan nanoparticles as a delivery system for CpG ODN has the potency to safely CpG ODN efficacy. [ABSTRACT FROM AUTHOR]

Onychomycosis is a nail infection caused by a fungus, Trichophyton mentagrophytes, that is responsible for major nail infections. The best method suited for treating such infections generally includes a topical remedy. However, conventional oral or topical formulations are associated with various limitations. Therefore, a more efficient and compatible formulation is developed in this study. The primary objective of the current study is to formulate and evaluate chitosan nanoparticle-based hydrogel for ameliorating onychomycosis. The sole purpose of this research was to increase the permeation of the lipophilic drug itraconazole and difluorinated curcumin, and its synergistic antifungal activity was also evaluated for the first time. Both in vitro and ex vivo drug release evaluations confirmed the sustained release of both drugs from the hydrogel, which is a prerequisite for treating onychomycosis. The results overall highlighted the promising activity of a synergistic approach that could be implemented for the treatment of onychomycosis. The hydrogel-based formulation serves as an effective method of delivery of drugs across the layers of the skin, resulting from its hydrating characteristics. [ABSTRACT FROM AUTHOR]

The controlled-release characteristic of drug delivery systems is utilized to increase the residence time of therapeutic agents in the human body. This study aimed to formulate and characterize salsalate (SSL)-loaded chitosan nanoparticles (CSNPs) prepared using the ionic gelation method and to assess their in vitro release and antibacterial and antibiofilm activities. The optimized CSNPs and CSNP–SSL formulation were characterized for particle size (156.4 ± 12.7 nm and 132.8 ± 17.4 nm), polydispersity index (0.489 ± 0.011 and 0.236 ± 132 0.021), zeta potential (68 ± 16 mV and 37 ± 11 mV), and entrapment efficiency (68.9 ± 2.14%). Physicochemical features of these nanoparticles were characterized using UV–visible and Fourier transform infrared spectroscopy and X-ray diffraction pattern. Scanning electron microscopy studies indicated that CSNPs and CSNP–SSL were spherical in shape with a smooth surface and their particle size ranged between 200 and 500 nm. In vitro release profiles of the optimized formulations showed an initial burst followed by slow and sustained drug release after 18 h (64.2 ± 3.2%) and 48 h (84.6 ± 4.23%), respectively. Additionally, the CSNPs and CSNP–SSL nanoparticles showed a sustained antibacterial action against Staphylococcus aureus (15.7 ± 0.1 and 19.1 ± 1.2 mm) and Escherichia coli (17.5 ± 0.8 and 21.6 ± 1.7 243 mm). Interestingly, CSNP–SSL showed better capability (89.4 ± 1.2% and 95.8 ± 0.7%) than did CSNPs in inhibiting antibiofilm production by Enterobacter tabaci (E2) and Klebsiella quasipneumoniae (SC3). Therefore, CSNPs are a promising dosage form for sustained drug delivery and enhanced antibacterial and antibiofilm activity of SSL; these results could be translated into increased patient compliance. [ABSTRACT FROM AUTHOR]

Recently, various innovative technologies have been developed for the enhanced delivery of biologics as attractive formulation targets including polymeric micro and nanoparticles. Combined with personalized medicine, this area can offer a great opportunity for the improvement of therapeutics efficiency and the treatment outcome. Herein, a novel manufacturing method has been introduced to produce protein-loaded chitosan particles with controlled size. This method is based on an additive manufacturing technology that allows for the designing and production of personalized particulate based therapeutic formulations with a precise control over the shape, size, and potentially the geometry. Sprayed multi adsorbed-droplet reposing technology (SMART) consists of the high-pressure extrusion of an ink with a well determined composition using a pneumatic 3D bioprinting approach and flash freezing the extrudate at the printing bed, optionally followed by freeze drying. In the present study, we attempted to manufacture trypsin-loaded chitosan particles using SMART. The ink and products were thoroughly characterized by dynamic light scattering, rheometer, Scanning Electron Microscopy (SEM), and Fourier Transform Infra-Red (FTIR) and Circular Dichroism (CD) spectroscopy. These characterizations confirmed the shape morphology as well as the protein integrity over the process. Further, the effect of various factors on the production were investigated. Our results showed that the concentration of the carrier, chitosan, and the lyoprotectant concentration as well as the extrusion pressure have a significant effect on the particle size. According to CD spectra, SMART ensured Trypsin's secondary structure remained intact regardless of the ink composition and pressure. However, our study revealed that the presence of 5% (w/v) lyoprotectant is essential to maintain the trypsin's proteolytic activity. This study demonstrates, for the first time, the viability of SMART as a single-step efficient process to produce biologics-based stable formulations with a precise control over the particulate morphology which can further be expanded across numerous therapeutic modalities including vaccines and cell/gene therapies. [ABSTRACT FROM AUTHOR]

Herbs and hand-made herbal remedies have been long used for disease control, treatment, and health improvement. Evidence suggests that a single herb's compounds can have synergistic functions with probably no adverse effect. Unfortunately, the traditional administration of essential oil (EO) does not follow a regulatory dose regimen, causing reduced bioavailability due to EO evaporation or denaturation in harsh biological environments. Hence, encapsulation can help enhance EO stability and dose dependence. Here, chitosan nanoparticles (ChNPs) were used to encapsulate frankincense essential oil (FEO) to preserve its remarkable therapeutic effects. Also, traditional bulk preparation methods were compared with microfluidic with central aqueous stream configuration (CAS). The results indicated the higher quality of microfluidic-based nanoparticles with uniform, spherical, and separated morphologies. The size of bulk and microfluidic nanoparticles ranged from 86 to 118 nm, the surface charge varied from 12.5 to 19.5 for different amounts of FEO, and the as-prepared colloid remained stable for three days. Narrow size distribution (PDI≤0.28) and high encapsulation efficiency (EE≤99 %) were achieved using the microfluidic process compared to the bulk method (PDI=0.74, EE≤90 %). The microfluidic nanoparticle also indicated a burst release rate greater than the bulk method (≤30 %). It was concluded that the high-performance microfluidic approach provided higher quality and more control over nanoparticle properties. [ABSTRACT FROM AUTHOR]

The aim of this survey was to fabrication of chitosan nanoparticle was loaded by Boswellia sacra essential oil (BS-CNPs) and investigation of its pharmacological activities.BS-CNPs was synthesized by ionic gelation method and characterized. BS-CNPs-mediated cell viability and cell death were studied by MTT, qPCR, AO/PI staining and flow cytometery. Anti-angiogenesis properties were evaluated by CAM and scratch assay. Anti-oxidant properties were assessed by ABTS, DPPH, FRAP and ROS assay. The BS-CNPs (80.13 nm, ζ-p 39.20 mv and %EE: 82.7%) exhibited selective cytotoxicity on HepG2 cells (IC50:62.94 μg/ml). BS-CNPs induced the apoptosis by up-regulation of P53, Cas-3 and 9. Increasing the rate of free radical scavenging and intracellular ROS confirmed the anti and pro-oxidant potential of BS-CNPs outside and inside of cancer cells.Inhibition (92.3%) of cell migration, reduction of angiogenic factors showed anti-angiogenic effects of BS-CNPs.BS-CNPs due tounique anti-cancer properties are suitable for therapeutic targets in cancer studies. [ABSTRACT FROM AUTHOR]

This study was designed to investigate the anticancer properties of Cerium oxide nanoparticle (nanoceria)-loaded on chitosan (CeCh-NPs). Nanoceria were prepared using melon shell extract by green synthesis method and then loaded on chitosan biopolymers by ion gelation method. The prepared nanoceria were characterised using DLS, XRD, FT-IR, FESEM and TEM studies. CeCh-NPs were characterised with DLS, Zeta potential and FESEM methods. The cytotoxicity of CeCh-NPs was evaluated by MTT method and the following the Flow cytometry, gene expression analysis and AO/PI staining methods were used to assess the occurrence of apoptosis. The antioxidant effects of CeCh-NP were investigated by qPCR. The FTIR and XRD results confirmed the presence of Ce-NPs and then the results of DLS, TEM and FESEM showed the formation of spherical nanoparticles with a size of 54.83 nm and PDI of 0.31. Data from physicochemical analysis of CeCh-NPs showed the formation of spherical nanoparticles with a diameter of 63.68 nm, PDI of 0.34 and zeta potential of 44.06 Mv. The IC50 of CeCh-NPs for HFF and A549 cells were reported about 50.65 and 131.108 μg/ml, respectively. Increasing the number of cells in the SubG1 phase in flow cytometry, increased expression of caspase 9 genes in treated cells and also AO/PI results confirmed the occurrence of apoptosis in CeCh-NPs-treated cells. On the other hand, induction of cell death was observed by reducing the expression of antioxidant genes (CAT, SOD) in CeCh-NPs-treated cells. The CeCh-NPs induced apoptosis and inhibited cancer cells by various mechanisms, including activation of the internal pathway of apoptosis (cas-9) and reduction of antioxidant genes. Therefore, CeCh-NPs can be suggested as an effective factor in cancer therapy studies. [ABSTRACT FROM AUTHOR]

The present work-study the decreasing fluoride ions toxicity on the rat heart via loading them on the chitosan nanoparticles (Cs NPs) surface to form the biologically compatible composite (Cs@NaF). The obtained nanocomposite was characterized by different techniques such as field emission scanning electron microscopy (FEG-SEM), zeta potential, and x-ray diffraction (XRD). The biochemical parameters in the albino rats perform, where twenty-eight male adult Sprague Dawley rats (average body weight of 150 ± 10 g) were obtained from the Faculty of Agriculture, Alexandria University, then acclimatized for two weeks before the experiment and divided into four groups in galvanized wire cages at room temperature (22–25 °C) with a 12-h photoperiod and fed a well-balanced commercial diet. The blood samples were obtained from the vena cava of the rat heart via estimation of the troponin T, Lactate dehydrogenase, and creatine phosphokinase. Also, immunoglobulins (IgA, IgM, and IgG) and hematological measurements have been performed on the rat heart. To express all of the data, the mean and standard error of the mean are utilized by (ANOVA), followed by Tukey's multiple comparison test. The modified chitosan with fluoride decreases the toxicity of fluoride via improving the rat heart function due to the presence of Cs NPs helped to mitigate some of the negative effects of fluoride therapy. [Display omitted] • Chitosan-fluoride decreases fluoride toxicity via improving the heart function. • Chitosan-fluoride reduced the changes in total protein and albumin compared to NaF. • Chitosan-fluoride has a protective impact on liver cells by lowering marker enzymes. • Chitosan helped to mitigate some of the negative effects of fluoride therapy. [ABSTRACT FROM AUTHOR]

Infection stones constitute a small but intractable group of diseases of urinary system. In this study, we explored the potential therapeutic effect of a small activation RNA, ds-320, encapsulated in chitosan (320-chitosan). Western blot analysis verified the downregulation of TRPV5 in patients and rat model of infection stones, as well as the stimulation of ds-320 on TRPV5 expression. MTT assay showed that chitosan-mediated delivery was less cytotoxic to ds-320 compared with liposome delivery. Further a modified invasion assay revealed an inhibitory effect of 320-chitosan on bacterial invasion into normal rat kidney epithelial NRK-52E cells. The establishment of infection stone model was performed by intravesical injection of 1x108 CFU of Proteus mirabilis. In animal experiments, no visible stones were obtained. The number of live bacteria and white blood cells in urine showed no difference among all infected rats at the time of sacrifice. However, we observed a decline in urine calcium and pH, suggesting the effect of acidification. Overall, our study provides evidence for the protective effect of 320-chitosan, for its ability to down-regulate urinary calcium, acidify urine, and inhibit bacteria from invading renal epithelial cells. Thus, it can be served as an important complementary therapy for infection stones. [ABSTRACT FROM AUTHOR]

The self-assembly of cisplatin (Cis-Pt) and chitosan nanoparticles (Cs NPs) has been synthesized and characterized successfully by different analyses and techniques, such as scanning electron microscopy, ultraviolet–visible spectrophotometry, and Fourier transform infrared spectroscopy. The efficiency of loading Cis-Pt on Cs NPs for decreasing the side effects of Cis-Pt by loading it on Cs NP surface was revealed through histopathological and physiological measurements for the liver, testis, and kidney cells. Self-assembly hybrid nanocomposite (Cis-Pt@Cs) could improve spermatogenic cells, seminiferous tubules, and Leydig cells in the interstitial tissue. Kidney examination showed intact glomeruli with a mild increase in capsular space in addition to the intact renal tubular epithelial lining, and liver findings showed improvement in dilation and congestion of the central vein besides mild dilation of blood sinusoids in addition to a mild degree of hepatocyte vacuolation. The serum levels of hepatic, renal, and testicular marker analysis were measured, where Cis-Pt increased the serum levels of alanine aminotransferase, aspartate aminotransferase activity, urea, creatinine, and decreased testosterone levels, while synthesized self-assembly appeared normalized levels. From the results, the self-assembly hybrid nanocomposite decreases and improves the side effects of Cis-Pt. [ABSTRACT FROM AUTHOR]